Delivery Order SPE2DB22D3004-SPE2DB24FQU77

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, awarded by the Defense Logistics Agency (DLA), is for the delivery of 4564313057 - FLUOROMETHOLONE 0.1% EYE DROP 10ML. The contract has a ceiling value of $6,744.08, a firm fixed price pricing type, and an ultimate completion date of April 18, 2024. This contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.86 firm fixed-price delivery order contract is for the supply of FLUOROMETHOLONE 0.1% EYE DROP 5ML, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $4,034.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorometholone 0.1% eye drops, a pharmaceutical product used for various ophthalmic conditions. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed-price delivery order. No set-aside designation was used for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,244.37 firm fixed-price delivery order is for the supply of Fluorometholone 0.1% eye drops, a medication used to treat various eye conditions. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide pharmaceutical and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,132.34, is a Firm Fixed Price Delivery Order for the supply of FLUOROMETHOLONE 0.1% EYE DROP 5ML. The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. government agency Defense Logistics Agency (DLA) awarded a $17,161.88 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLUOROMETHOLONE 0.1% EYE DROP 5ML, with a period of performance through February 27, 2025. This contract award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $4,228.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorometholone 0.1% eye drops, a medical product used in the treatment of various eye conditions. The contract has an ultimate completion date of January 29, 2025 and is structured as a Firm Fixed Price Delivery Order. The award is not associated with a...
This federal contract award, valued at $1,115.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorometholone 0.1% eye drops, a medical product used in various healthcare applications. This contract award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $4,478.06 firm-fixed-price delivery order is for the supply of 5 ml bottles of Fluorometholone 0.1% eye drops. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to procure a comprehensive range of...
This federal contract award, valued at $3,036.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorometholone 0.1% eye drops in 5ml containers. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of June 14, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQU77
    Delivery Order

This federal contract award, valued at $4,891.02, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of FLUOROMETHOLONE 0.1% EYE DROP 5ML, a pharmaceutical product, with a completion date of June 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. This specific contract award is not designated as a set-aside.

Generated 9/20/24, 9:32 AM